Skeletal muscle disorder
MONDO:0020120A disease involving the skeletal muscle tissue.
Also known as: disease of skeletal muscle tissue, disease or disorder of skeletal muscle tissue, disorder of skeletal muscle tissue, skeletal muscle tissue disease, skeletal muscle tissue disease or disorder
1194 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Hope for muscle strength: experimental drug tested for Long-Term use in rare muscular dystrophy
Disease control OngoingThis study tests the long-term safety and effectiveness of an experimental drug called BBP-418 (ribitol) in people with limb-girdle muscular dystrophy type 2I/R9, a rare genetic muscle-weakening disease. Participants who completed a previous study will take BBP-418 orally twice d…
Phase: PHASE3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Vertex tests long-term safety of VX-670 for muscle disease
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of an experimental drug called VX-670 in adults with myotonic dystrophy type 1 (DM1). Participants who completed a previous VX-670 study can join. The drug is given through a vein, and researchers will monitor side effects a…
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for duchenne? experimental drug BMN 351 enters human testing
Disease control OngoingThis early-stage trial is testing a drug called BMN 351 in 18 boys aged 4 to 10 with Duchenne muscular dystrophy who have a specific genetic change. The drug is designed to help the body produce a shorter but still useful version of the muscle protein dystrophin. The main goal is…
Phase: PHASE1, PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental cell therapy takes on hard-to-treat muscle disease
Disease control OngoingThis study tests a new treatment called rapcabtagene autoleucel for people with severe idiopathic inflammatory myopathies (muscle inflammation) that hasn't improved with standard therapies. About 21 adults will receive either this cell therapy or a comparator. The main goal is to…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New antibody aims to block muscle wasting in rare disease
Disease control OngoingThis Phase 2 trial tests a drug called RO7204239 in 51 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. The drug is an antibody that blocks myostatin, a protein that normally limits muscle growth, to help pres…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene therapy RGX-202 made available for single patients in need
Disease control TEMPORARILY_NOT_AVAILABLEThis program allows eligible patients to receive RGX-202, a gene therapy, on a single-patient basis outside of a clinical trial. It is designed for those with serious conditions who have no other treatment options. Currently, the program is temporarily not available.
Sponsor: REGENXBIO Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-stage trial is testing a new treatment called KITE-363 for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard treatments. KITE-363 is a type of cell therapy where a patient's own immune cells are modified in a lab to t…
Phase: PHASE1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for duchenne: experimental drug aims to restore muscle protein
Disease control OngoingThis early-stage trial is testing a drug called NS-050/NCNP-03 in 20 boys with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The drug is designed to skip a faulty section of the dystrophin gene, allowing the body to produce a shorter but still functional…
Phase: PHASE1, PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for Long-Term control of rare muscle disease
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of a drug called efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy, a group of rare muscle diseases. Participants who completed a previous trial will receive the drug as a shot under the skin for up to 51 months. The…
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Heart cell therapy shows promise for duchenne MD in major trial
Disease control OngoingThis Phase 3 trial tests a cell therapy called deramiocel (CAP-1002) in 106 boys and young men with Duchenne muscular dystrophy. Participants receive either the cell therapy or a placebo every 3 months for a year, then all can receive the therapy for another year. The goal is to …
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells aim to tame autoimmune attacks
Disease control TerminatedThis early-phase trial tests a new cell therapy called BEN301 for several autoimmune diseases, including scleroderma and rheumatoid arthritis. The therapy uses specially engineered immune cells (CAR-Treg cells) to calm the overactive immune system. The study involves 24 adults an…
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug aims to tame muscle inflammation in myositis
Disease control OngoingThis phase 2 trial tests whether nipocalimab, given intravenously, can improve symptoms of active idiopathic inflammatory myopathies (myositis) better than a placebo. About 36 adults with myositis will receive either nipocalimab or a placebo, along with standard steroid treatment…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New implant aims to fix torn shoulder tendons
Disease control OngoingThis early study tests a new device called SINEFIX to repair small rotator cuff tears (up to 2 cm) in 9 adults. The implant is placed during keyhole surgery to reattach the torn tendon to the bone. Researchers will use MRI scans to check if the tendon heals properly and if there …
Phase: NA • Sponsor: BAAT Medical Products B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gene therapy trial aims to slow duchenne muscular dystrophy in boys
Disease control OngoingThis study tests a single dose of SGT-001 gene therapy in 12 boys (children and teens) with Duchenne muscular dystrophy. The main goal is to check safety and how well the body tolerates the treatment. Participants will be followed for about 5 years to monitor side effects and any…
Phase: PHASE1, PHASE2 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New study tracks Long-Term safety of rare disease treatment
Disease control OngoingThis study follows 150 people with long-chain fatty acid oxidation disorders (LC-FAOD) to check the long-term safety of their treatment, including for pregnant women and their babies. Researchers track serious side effects and disease complications. The goal is to better understa…
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
CAR T-Cell trial for lupus and myositis pulled before starting
Disease control TerminatedThis study aimed to test a new type of cell therapy (called CAR T-cells) in people with severe lupus or inflammatory myopathy that did not get better with standard treatments. The therapy uses donor cells to target and destroy faulty immune cells. However, the study was withdrawn…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Gene therapy breakthrough? new trial targets duchenne muscular dystrophy
Disease control OngoingThis Phase 3 trial tests a gene therapy called SRP-9001 for Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. It includes 148 males who can and cannot walk. Participants receive a one-time IV infusion of the therapy or a placebo, and are followed for about 128 w…
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New implant aims to strengthen shoulder tendon repair after replacement
Disease control OngoingThis study is testing a special implant (Tapestry) that helps repair a key shoulder tendon (subscapularis) during shoulder replacement surgery. About 100 adults with shoulder arthritis or injury will be followed for 2 years to see if the tendon heals better with the implant. The …
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill aims to slow muscle damage in becker MD
Disease control OngoingThis phase 2 trial tests a daily oral drug called sevasemten (EDG-5506) in 244 adults and adolescents with Becker muscular dystrophy, a condition that causes progressive muscle weakness. The study compares the drug to a placebo to see if it can reduce muscle damage, improve walki…
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could an arthritis drug help kids with duchenne MD? new trial aims to find out
Disease control OngoingThis study tests satralizumab, a drug that calms inflammation, in 30 children aged 8 to 17 with Duchenne muscular dystrophy. The goal is to see if it improves bone density and muscle function. Participants receive injections for several months while continuing standard steroid th…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for DMD: Long-Term trial of weekly infusions begins
Disease control ENROLLING_BY_INVITATIONThis study is for people with Duchenne muscular dystrophy (DMD) who have already taken part in a previous trial of BMN 351. It tests the long-term safety of weekly intravenous infusions of BMN 351 and whether it helps maintain physical function. Only 18 participants will be enrol…
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Hip replacement bleeding breakthrough: drug could cut transfusions
Disease control OngoingThis study tests whether tranexamic acid, a drug that helps blood clot, can reduce blood loss during planned hip replacement surgery. About 1000 adults having elective hip replacement will receive the drug directly into the joint during surgery. The goal is to see if it lowers th…
Sponsor: St. Anne's University Hospital Brno, Czech Republic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for FSHD: Long-Term drug safety trial underway
Disease control OngoingThis study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Gene therapy trial targets duchenne in toddlers
Disease control OngoingThis study tests a gene therapy called delandistrogene moxeparvovec in 13 children under age 4 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help produce a key muscle protein. The children will be followed for about 5 years.
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hope for becker MD: new drug shows promise in Long-Term trial
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a drug called EDG-5506 (sevasemten) in people with Becker muscular dystrophy, a muscle-weakening disease. About 260 adults and teens who were in earlier EDG-5506 studies will take the drug and be monitored for side effects a…
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Gene therapy vs. standard care: new study tracks Long-Term outcomes in duchenne patients
Disease control ENROLLING_BY_INVITATIONThis study follows 500 people with Duchenne muscular dystrophy to see how well a gene therapy (ELEVIDYS) works compared to standard steroid treatment over time. Researchers will measure movement abilities, breathing, and safety, including liver problems. Participants must already…
Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for MELAS: experimental drug tested for Long-Term safety
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety of a daily oral drug called zagociguat in 44 adults with MELAS, a rare genetic disease that affects energy production in cells. All participants previously completed a lead-in study of the same drug. Researchers will monitor side effects…
Phase: PHASE2 • Sponsor: Tisento Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail shows promise for rare muscle disease
Disease control OngoingThis phase 2 study tests a combination of two nucleoside drugs, doxecitine and doxribtimine, in 47 people with thymidine kinase 2 (TK2) deficiency, a rare genetic disorder that weakens muscles. Participants already receiving nucleoside therapy continue treatment to see if the dru…
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New shoulder implant tracked in 200 patients for pain and function
Disease control OngoingThis study follows 200 adults getting a shoulder replacement with the Zimmer Trabecular Metal Reverse Shoulder System. It aims to see how long the implant lasts and how well it relieves pain and improves movement in people with conditions like arthritis, fractures, or failed prio…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a common diabetes drug help seniors heal faster after a broken hip?
Disease control ENROLLING_BY_INVITATIONThis pilot study tests whether metformin, a common diabetes drug, can help older adults recover muscle and function after a hip fracture. Sixty people aged 60 and older will take either metformin or a placebo daily for 4 months after surgery. The main goal is to see if the study …
Phase: EARLY_PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can your own fat cells fix a torn rotator cuff?
Disease control OngoingThis phase 2 trial tests whether a patient's own fat-derived cells (stromal vascular fraction) can improve healing after surgical repair of a chronic rotator cuff tear. The study enrolls 56 adults aged 45-65 with full-thickness tears who have not improved with physical therapy. T…
Phase: PHASE2 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Gene therapy could end frequent eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to help the eye produce its own medicine to stop leaky blood vessels, potentially replacing the need for repeated eye injecti…
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a headset tame inflammation in duchenne muscular dystrophy?
Disease control ENROLLING_BY_INVITATIONThis pilot study tests a device called Travagus One, which stimulates a nerve in the ear to reduce inflammation in boys with Duchenne muscular dystrophy (DMD). Twenty boys aged 5-17 will use the headset at home for 5 minutes twice a day for one week. Researchers will measure infl…
Phase: NA • Sponsor: taVNS AB • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks bone safety of DMD drug vamorolone over years
Disease control OngoingThis study follows about 80 boys with Duchenne muscular dystrophy who have already taken vamorolone in earlier studies. Researchers want to see how safe the drug is over a longer time, especially its effect on bone health, like spine fractures. The boys continue taking vamorolone…
Phase: PHASE4 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug SAT-3247 tested for long-term muscle protection in duchenne MD
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a drug called SAT-3247 in 10 people with Duchenne muscular dystrophy who were in a previous trial. Participants take the drug by mouth five days a week for about 11 months. Researchers will check for side effects and measure…
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 underway
Disease control ENROLLING_BY_INVITATIONThis phase 3 study is testing the long-term safety and effectiveness of an experimental drug called AOC 1001 (del-desiran) for people with myotonic dystrophy type 1 (DM1), a genetic muscle disorder. The trial enrolls 230 adults who have completed a prior AOC 1001 study and will r…
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Fat stem cells may speed shoulder tear recovery
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding stem cells from a patient's own fat tissue to standard rotator cuff surgery can improve healing and reduce recovery time. About 30 adults with shoulder tendon tears will receive the stem cell injection during surgery. The goal is to see if this sim…
Phase: PHASE1 • Sponsor: University of Southern Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gene therapy trial for rare muscle disease halted after severe side effects
Disease control OngoingThis trial tested a gene therapy called AT132 for X-linked myotubular myopathy (XLMTM), a rare muscle disease present at birth that causes severe breathing problems. The therapy aimed to deliver a healthy copy of the MTM1 gene to improve muscle function. However, the study was st…
Phase: PHASE2, PHASE3 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could stem cells slow MSA? new trial tests safety and effects
Disease control OngoingThis study tests whether a person's own stem cells can be safely injected into the spinal fluid to treat multiple system atrophy (MSA), a rare and serious brain disease. About 30 adults aged 30-80 with MSA will receive the treatment. The main goal is to check for side effects, an…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug GRT6019 takes first step toward duchenne treatment
Disease control OngoingThis early-phase trial tests the safety and tolerability of a new drug called GRT6019 in 24 healthy men. Participants receive multiple doses over 4 weeks and are monitored for side effects and how the drug moves through the body. The goal is to see if GRT6019 is safe enough to st…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental drug hopes to slow rare muscle disease in two patients
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a daily injection of ASA-001 in two adults with a rare genetic muscle disease (ADSS1 deficient myopathy). The main goals are to see if the drug is safe and if it can slow the disease. Participants will take the drug for 8 months and have clinic visits…
Phase: PHASE1 • Sponsor: Cure ADSSL1 • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug RAY121 tested for Long-Term control of autoimmune diseases
Disease control ENROLLING_BY_INVITATIONThis study is a long-term extension of an earlier trial, testing the safety of a drug called RAY121 in people with six different immune system disorders, including antiphospholipid syndrome and immune thrombocytopenia. Participants have already completed four doses of RAY121 and …
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New shoulder replacement system tracked in global study
Disease control ENROLLING_BY_INVITATIONThis study is following 110 people who received a Tornier HRS shoulder replacement to see how well it improves pain and function. Participants have conditions like arthritis, fractures, or rotator cuff tears. The goal is to collect long-term safety and performance data for regula…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Gene therapy for duchenne MD: Long-Term Follow-Up begins
Disease control ENROLLING_BY_INVITATIONThis study follows 66 boys with Duchenne muscular dystrophy who previously received RGX-202 gene therapy. Researchers will monitor side effects and measure muscle function over time, such as how fast they can stand, walk, or climb. The goal is to see if the treatment remains safe…
Sponsor: REGENXBIO Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill aims to ease fatigue and brain fog in rare mitochondrial disease
Disease control OngoingThis Phase 2b trial tests an oral drug called zagociguat in 43 adults with MELAS syndrome, a rare genetic disorder that causes fatigue, muscle weakness, and stroke-like episodes. Participants take either 15 mg, 30 mg, or a placebo daily for 12 weeks. The study measures changes in…
Phase: PHASE2 • Sponsor: Tisento Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Space suit that zaps muscles could keep astronauts fit on mars missions
Disease control ENROLLING_BY_INVITATIONThis study tests a special body suit that uses gentle electric pulses to stimulate muscles, helping astronauts exercise more efficiently in space. Twelve astronauts on the International Space Station will wear the suit during their workouts. Researchers will measure muscle stiffn…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a common drug ease painful jaw clicking?
Disease control OngoingThis study tests whether adding the drug sodium valproate to a standard jaw-washing procedure can lower inflammation in people with a painful jaw joint condition. Ten female participants with jaw clicking and pain will receive the drug intravenously during the procedure. Research…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Fish oil infusion may ease lung pressure in fragile newborns
Disease control ENROLLING_BY_INVITATIONThis study tests whether a special fish-oil emulsion given through an IV can improve outcomes for newborns with a diaphragm defect that causes severe lung pressure. About 40 babies will receive either the fish-oil emulsion or a standard soy-oil one. Researchers will measure lung …
Phase: PHASE2 • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Balloon in the womb could save babies with rare birth defect
Disease control OngoingThis study tests a procedure called FETO, where a tiny balloon is placed in the windpipe of unborn babies with severe congenital diaphragmatic hernia (CDH). The balloon helps the lungs grow before birth and is later removed. Researchers want to see if this improves survival and r…
Phase: NA • Sponsor: Inna Lobeck • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with autoimmune diseases like lupus, scleroderma, and vasculitis. Prula-cel uses donor immune cells engineered to target and destroy faulty immune cells that attack the body. The goal is to find a safe dose …
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Gene therapy hope for duchenne boys in first human test
Disease control OngoingThis early-stage trial tests a single dose of a gene therapy called JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy. The main goal is to check safety and tolerability, while also looking at whether it helps muscle function. It is a very small, first-in-human study, so…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Promising autoimmune therapy trial pulled before it even started
Disease control TerminatedThis study was designed to test a new treatment for people with autoimmune diseases like lupus, scleroderma, and myositis. It combined a specially engineered immune cell product (CLBR001) with a targeted antibody drug (SWI019), with or without a preparatory chemotherapy step. How…
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for duchenne: Long-Term drug safety trial underway
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of an experimental drug called WVE-N531 in people with Duchenne muscular dystrophy (DMD) who have already taken it in a previous study. About 175 participants will receive the drug and be monitored for side effects, heart and lung function…
Phase: PHASE2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
One-Time gene therapy aims to halt rare muscle disease
Disease control OngoingThis study tests a single dose of SRP-9003 gene therapy in 17 people with limb girdle muscular dystrophy 2E/R4, a genetic muscle-weakening disease. The goal is to restore a missing protein in muscle cells and improve muscle function. Both walkers and non-walkers can join, and the…
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy hope for boys with duchenne muscular dystrophy
Disease control OngoingThis study tests a gene therapy called PF-06939926 in 114 boys with Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. Two-thirds receive the gene therapy, while one-third get a placebo, but can switch to the real treatment after one year. The main goal is to see…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Higher dose of muscular dystrophy drug shows promise in new trial
Disease control OngoingThis Phase 3 trial tests whether higher doses of eteplirsen (Exondys 51) can safely improve muscle function in boys with Duchenne muscular dystrophy whose genetic mutation allows exon 51 skipping. About 160 ambulatory boys will receive one of three doses (30, 100, or 200 mg/kg) t…
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for myositis: early IVIg may boost recovery
Disease control OngoingThis study tests whether adding intravenous immunoglobulin (IVIg) to standard steroid treatment early in myositis helps patients improve faster. Myositis is a group of rare diseases causing muscle inflammation and weakness. The trial includes 44 adults diagnosed within the past y…
Phase: PHASE2, PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Experimental gene therapy targets rare muscle disease in first human test
Disease control OngoingThis early-phase trial tests a single-dose gene therapy called SRP-9003 in 6 people with limb girdle muscular dystrophy type 2E/R4, a rare genetic muscle-weakening disease. The main goals are to check safety and see if the therapy can produce the missing beta-sarcoglycan protein …
Phase: PHASE1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Immune system overhaul: could CAR T-Cells tame autoimmune disease?
Disease control OngoingThis early-stage trial is testing a new treatment called KYV-101 for people with severe autoimmune diseases like lupus, scleroderma, and vasculitis. The treatment involves taking a patient's own immune cells, modifying them to target and destroy faulty B cells, and giving them ba…
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can collagen and hyaluronic acid boost rotator cuff repair?
Disease control OngoingThis study tests whether injecting atelocollagen and hyaluronic acid during rotator cuff surgery improves healing. 124 people aged 40-75 with confirmed tears are enrolled. They receive one or both injections during arthroscopic repair and are followed for 2 years with MRI scans a…
Phase: NA • Sponsor: Hallym University Dongtan Sacred Heart Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Rare hernia surgery in older kids: what works best?
Disease control OngoingThis study looks at how children aged 1 month to 15 years with a late-diagnosed congenital diaphragmatic hernia (a hole in the muscle that separates the chest from the belly) do after surgery. Researchers reviewed 10 cases treated at one hospital with either keyhole or open surge…
Phase: NA • Sponsor: Jehad Emam Abdelrahman • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Shoulder surgery recovery: PRP vs steroids – which works better?
Disease control OngoingThis study compares two common injections—platelet-rich plasma (PRP) and corticosteroids—given during arthroscopic rotator cuff repair. 387 adults with full-thickness supraspinatus tears are randomly assigned to receive PRP, corticosteroid, or a placebo injection during surgery. …
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could CAR-T cells tame autoimmune diseases? early trial begins
Disease control TerminatedThis early-phase trial is testing a CAR-T cell therapy called RD06-04 in 12 people with active autoimmune diseases like lupus, scleroderma, and vasculitis. The treatment involves reprogramming a patient's own immune cells to target and destroy faulty B cells. The main goal is to …
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Immune cell therapy aimed at autoimmune diseases hits early snag
Disease control TerminatedThis early-phase trial planned to test a one-time infusion of genetically modified immune cells (CAR-T cells) targeting CD19 in people with several autoimmune diseases, including lupus and multiple sclerosis. The goal was to see if it was safe and could reduce harmful antibodies.…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Gene therapy hope for kids with rare muscle-wasting disease
Disease control OngoingThis early-stage trial tests a single intravenous dose of a gene therapy (ATA-200) in 4 children aged 6-12 with limb-girdle muscular dystrophy type 2C/R5 (LGMD2C), a rare genetic muscle-weakening condition. The goal is to see if the treatment is safe and tolerable by delivering a…
Phase: PHASE1 • Sponsor: Atamyo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a vitamin B3 pill help people with rare muscle disease?
Disease control OngoingThis study tests whether nicotinamide riboside, a form of vitamin B3, can improve walking distance and muscle function in adults with mitochondrial myopathy, a rare muscle disorder. Thirty-four participants receive either the supplement or a placebo for several months. The main g…
Phase: PHASE2 • Sponsor: Ralitza Gavrilova • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Hope for muscle strength: new drug targets myotonic dystrophy
Disease control OngoingThis phase 3 trial tests an experimental drug called AOC 1001 in 159 adults with myotonic dystrophy type 1, a genetic condition that causes muscle weakness and stiffness. Participants receive either the drug or a placebo by intravenous infusion. The main goal is to see if the dru…
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Surgery or rehab? new trial tackles stiff shoulder tears
Disease control OngoingThis study looks at the best way to treat partial rotator cuff tears in people who also have stiff shoulders. Half of the 80 participants will have early surgery, while the other half will follow a structured rehab program with the option of surgery later if needed. The goal is t…
Phase: PHASE1 • Sponsor: Hebei Medical University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New RNA drug hopes to slow duchenne muscle loss
Disease control OngoingThis early-phase trial tests a new drug called RAG-18 in 12 boys aged 4-15 with Duchenne muscular dystrophy. The drug is a small activating RNA given through an IV, designed to help muscles work better. The main goal is to check safety and how the body handles the drug, with earl…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Promising drug may halt extra bone formation in rare 'Stone Man' disease
Disease control OngoingThis study tests an experimental drug, garetosmab, in 63 adults with fibrodysplasia ossificans progressiva (FOP), a rare condition where soft tissues turn into bone. The goal is to see if the drug safely reduces new bone growth and painful flare-ups. Participants receive either t…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a transplant drug help patients with rare muscle disease?
Disease control OngoingThis phase 3 trial tests whether sirolimus, a drug used in organ transplants, can slow disease progression in people with inclusion body myositis (IBM), a rare muscle-weakening condition. The study involves 140 adults aged 45 and older who can walk at least 200 meters. Over 84 we…
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Engineered immune cells take on lupus and scleroderma in first human test
Disease control OngoingThis early-stage study is testing a new treatment called CNTY-101 for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myopathies that haven't improved with standard therapies. CNTY-101 uses specially engineered immune cells to target and destroy f…
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New shoulder implant tested for long-term relief in severe tears and arthritis
Disease control OngoingThis study follows 200 adults who receive the Shoulder iD™ implant to treat severe rotator cuff tears or shoulder arthritis. Researchers measure how well the shoulder works and how often the implant needs to be fixed or replaced over 10 years. Participants attend regular check-up…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New stem cell approach aims to tame rare genetic diseases
Disease control OngoingThis study tests a stem cell transplant method for people with inherited metabolic disorders and severe osteopetrosis. The goal is to get the donor cells to take hold while keeping side effects low. Participants receive chemotherapy drugs before the transplant to prepare their bo…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
App-Based rehab could replace office visits after shoulder surgery
Disease control ENROLLING_BY_INVITATIONThis study compares two ways to recover after reverse total shoulder replacement: using a smartphone app (mymobility) for home exercises versus standard in-person physical therapy. Researchers will enroll 100 adults to see if the app works just as well. The main goal is to measur…
Phase: NA • Sponsor: Campbell Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Rare bone disease patients get early access to experimental drug
Disease control TEMPORARILY_NOT_AVAILABLEThis program offers garetosmab to adults with fibrodysplasia ossificans progressiva (FOP) who finished the main OPTIMA study. The goal is to provide the drug before it is officially approved. Participants must meet specific health criteria to join.
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Metformin may shield aging muscles from inactivity
Disease control OngoingThis early-phase trial tests whether metformin, a widely used diabetes drug, can prevent muscle loss and insulin resistance in healthy older adults during five days of bed rest. Researchers will measure changes in muscle size and insulin sensitivity. The study involves 64 partici…
Phase: EARLY_PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could donor cells boost rotator cuff repair? early trial begins
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests whether injecting special donor cells (E-CEL UVEC) into the shoulder during rotator cuff surgery is safe and might improve healing. Twenty adults aged 45-70 with full-thickness tears will receive the cells at the repair site. The main goal is to check…
Phase: PHASE1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Promising psoriasis drug study for rare muscle disease pulled before start
Disease control TerminatedThis study planned to test deucravacitinib, a drug already approved for psoriasis, in adults with hard-to-treat dermatomyositis (DM) or juvenile dermatomyositis (JDM). Participants would have taken a pill twice daily for 24 weeks, with clinic visits every 4 weeks. However, the st…
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New shoulder implant tested for arthritis and rotator cuff tears
Disease control OngoingThis study is testing a shoulder replacement device called the Medacta Shoulder System in 100 people with shoulder arthritis or rotator cuff tears. The goal is to see how well the implant works after 2 years, focusing on shoulder function, safety, and patient satisfaction. Partic…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New shoulder implant aims to cut Re-Tear rates after rotator cuff surgery
Disease control TerminatedThis study tests a special implant called TAPESTRY that is placed during shoulder surgery to support healing of torn rotator cuff tendons. About 170 adults with partial or full-thickness tears will receive the implant and be followed for 6 months. The main goal is to see if the i…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug trial hopes to slow muscle damage in kids with DMD
Disease control OngoingThis study tests an experimental drug called sevasemten in 76 children aged 4-9 with Duchenne muscular dystrophy. The goal is to check the drug's safety, how the body processes it, and its effect on muscle health markers. Participants are randomly assigned to receive the drug or …
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for duchenne kids: drug combo after gene therapy tested
Disease control OngoingThis study tests an experimental drug called EDG-5506 (sevasemten) in 43 children and teens aged 6 to 17 with Duchenne muscular dystrophy who have already received gene therapy. The goal is to see if the drug is safe and how it affects muscle damage markers. Participants are rand…
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Hope for duchenne: new cell therapy shows promise in Long-Term trial
Disease control OngoingThis study tests the long-term safety and effectiveness of a cell therapy called deramiocel (CAP-1002) in people with Duchenne muscular dystrophy who completed the earlier HOPE-2 trial. Participants receive an infusion of deramiocel every 3 months for about 5 years, with the opti…
Phase: PHASE2 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New shoulder implant study aims to ease severe arthritis and rotator cuff damage
Disease control ENROLLING_BY_INVITATIONThis study is tracking 175 people who receive a Biomet Comprehensive Reverse Shoulder implant to see how much their pain and shoulder function improve over one year and beyond. Participants have severe shoulder problems like arthritis or a torn rotator cuff that cannot be repaire…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Balloon in the womb: new hope for babies with underdeveloped lungs?
Disease control OngoingThis pilot study tests a procedure called FETO in 14 unborn babies with severe left congenital diaphragmatic hernia (CDH), a birth defect where abdominal organs push into the chest and stunt lung growth. Doctors place a tiny balloon in the baby's windpipe via fetoscopy to trap lu…
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a Weight-Loss drug protect muscle and bone in seniors? new study aims to find out
Disease control OngoingThis pilot study is testing the drug tirzepatide (Zepbound) in 40 older adults with obesity to see how it affects body composition, bone density, and physical function over nine months. Participants take weekly injections, track their diet and activity, and attend regular check-i…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New shoulder implant under scrutiny: will it hold up?
Disease control OngoingThis study follows 99 people who received a specific shoulder replacement system to see how well it works and if it is safe. Participants had severe shoulder arthritis, a torn rotator cuff, or a failed prior shoulder replacement. The main goal is to track how long the implant las…
Phase: NA • Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could this drug stop the body from turning muscle into bone?
Disease control OngoingThis study tests an experimental drug called andecaliximab in 92 children and adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic condition where soft tissues turn into bone. The goal is to see if the drug can safely reduce new bone growth and flare-ups. Parti…
Phase: PHASE2, PHASE3 • Sponsor: Ashibio Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
In-Womb balloon procedure could save babies with rare birth defect
Disease control OngoingThis study tests a procedure called FETO, where a tiny balloon is placed in the windpipe of a fetus with severe left congenital diaphragmatic hernia (CDH). The balloon blocks fluid from leaving the lungs, causing them to grow larger before birth. The goal is to improve survival f…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Experimental gene therapy targets rare muscle disease
Disease control OngoingThis early-stage trial tests a gene therapy called ATA-100 for people with LGMDR9, a rare genetic muscle disease that causes progressive weakness. Six adults receive a single intravenous infusion of the therapy, which delivers a working copy of the FKRP gene. The main goal is to …
Phase: PHASE1 • Sponsor: Atamyo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Desperate hope: stem cells tested on one child with rare muscle disease
Disease control NO_LONGER_AVAILABLEThis trial gives a single child with a rare form of congenital muscular dystrophy access to their own banked stem cells. The cells are given through 14 IV infusions to see if they are safe and can help control the disease. Because it involves only one patient, the results will be…
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New shoulder implant tracked in 200 patients for lasting relief
Disease control OngoingThis study follows 200 adults who received the Medacta Shoulder System to treat shoulder problems like arthritis, fractures, or to replace a previous implant. Researchers are checking how long the implant lasts, how well the shoulder works, and any side effects. The goal is to co…
Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New pill could tame rare Muscle-Skin disease
Disease control OngoingThis phase 3 trial tests an oral drug called brepocitinib in 241 adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. Participants receive either the drug or a placebo for 52 weeks to see if it improves symptoms. The study is active but no longer rec…
Phase: PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Hope for rare muscle disease: new drug enters final testing phase
Disease control OngoingThis study tests a drug called BBP-418 (Ribitol) in 81 people aged 12 to 60 with limb girdle muscular dystrophy type 2I (LGMD2I), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo for 36 months to see if it slows the di…
Phase: PHASE3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug hopes to tame rare muscle and skin disease
Disease control OngoingThis study tests a drug called empasiprubart in adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. Three participants receive either the drug or a placebo for 25 weeks, then are followed for 65 more weeks. The goal is to see if the drug is safe and…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug shows promise in slowing duchenne muscle loss
Disease control OngoingThis study tests the long-term safety and effectiveness of an experimental drug called DS-5141b (Renadirsen) in 8 people with Duchenne muscular dystrophy who have already completed a previous study. Participants receive a weekly injection under the skin. Researchers will monitor …
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
Timing of cord clamp could save lungs in rare birth defect
Disease control OngoingThis study tests whether waiting to clamp the umbilical cord until after the baby's lungs have filled with air can reduce dangerous lung blood pressure (pulmonary hypertension) in newborns with congenital diaphragmatic hernia (CDH). About 140 infants with left-sided CDH will be r…
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:00 UTC
-
New stitching device aims to heal torn shoulder tendons better
Disease control ENROLLING_BY_INVITATIONThis study tests a new flexible suturing system with anchors (FSSA) to repair full-thickness rotator cuff tears. About 100 people who have had this surgery will get an MRI one year later to check if the tendon has healed. The goal is to see if this device helps tendons heal more …
Sponsor: Integrity Orthopaedics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
New drug TAS-205 aims to help kids with duchenne walk better
Disease control OngoingThis Phase 3 trial tests whether TAS-205, an oral drug, can improve movement and safety in people with Duchenne muscular dystrophy. It includes 104 participants, both those who can walk and those who cannot. The study compares TAS-205 to a placebo over 52 weeks.
Phase: PHASE3 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:28 UTC
-
Can a new breathing workout help lung transplant patients breathe easier?
Disease control ENROLLING_BY_INVITATIONThis study compares two types of breathing muscle training in people who have had a lung transplant. One group does standard constant-resistance exercises, while the other adds short bursts of harder effort. The goal is to see which method better improves breathing strength and d…
Phase: NA • Sponsor: Hospital Universitario Marqués de Valdecilla • Aim: Disease control
Last updated Jun 26, 2026 14:58 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New shoulder dye could sharpen MRI images
Diagnosis OngoingThis study tests a new injection called NEMO-103 to see if it makes shoulder MRI pictures clearer for diagnosing problems like torn tendons or cartilage. About 85 adults with known or suspected shoulder issues will get both a regular MRI and one with the injection. The goal is to…
Phase: PHASE3 • Sponsor: Inventera Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Fetal lung MRI hopes to spot breathing trouble before birth
Diagnosis TerminatedThis study was designed to see if a special MRI technique (BOLD) could measure how well fetal lungs work in babies with diaphragmatic hernia or abdominal wall defects. Researchers planned to scan the lungs while the mother breathed normal air and then oxygen, looking for changes …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New tech aims to take the guesswork out of muscle pain diagnosis
Diagnosis OngoingThis observational study tests three non-invasive technologies—ultrasound, electrical impedance, and nerve excitability tests—to see if they can reliably diagnose myofascial pain syndrome. Researchers will compare results from 90 people with and without the condition. The goal is…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Scientists test new imaging to see muscle pain clearly
Diagnosis OngoingThis study aims to develop new imaging methods to better detect and understand myofascial pain, a common muscle pain condition. Researchers will compare 52 participants—some with myofascial pain and some healthy—using MRI, muscle electrical activity, and fiber-optic imaging. The …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New test could predict falls in muscle disease patients
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create a simple test battery to determine fall risk in people with neuromuscular disorders, such as muscular dystrophy or ALS. Researchers will assess 108 participants using several physical tests like walking, standing, and rising from a chair. The goal is to …
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Jun 26, 2026 16:30 UTC
-
Shingles vaccine trial aims to protect vulnerable patients
Prevention OngoingThis study tests the Shingrix vaccine in over 2,000 adults with autoimmune rheumatic diseases like rheumatoid arthritis and lupus, who are at higher risk for shingles. Researchers will compare vaccinated patients to unvaccinated ones to see if the vaccine is safe and triggers a s…
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Which exercise heals the knee tendon best? a Head-to-Head trial
Symptom relief ENROLLING_BY_INVITATIONThis study compares two 12-week exercise programs—eccentric training and heavy-slow resistance training—in 30 adults aged 18–50 with patellar tendinopathy (knee pain lasting over 3 months). Researchers measure changes in tendon thickness, stiffness, strength, and pain to see whic…
Phase: NA • Sponsor: University of Graz • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Pilates and lifestyle counseling may offer Drug-Free relief for jaw pain
Symptom relief ENROLLING_BY_INVITATIONThis study compares lifestyle counseling alone versus lifestyle counseling combined with clinical Pilates in 62 women with temporomandibular disorders (TMD). Participants will be randomly assigned to one of two groups for 8 weeks. Researchers will measure pain, jaw function, post…
Phase: NA • Sponsor: Mustafa Kemal University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Ultrasound reveals how jaw pain treatments change muscles
Symptom relief OngoingThis study looks at how two common treatments for myofascial jaw pain—a mouth splint and lidocaine injections—affect the muscles of the jaw and neck. Researchers use ultrasound to see changes in muscle structure, like how well the muscle fibers reflect sound waves. The goal is to…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Which Non-Surgical treatment eases shoulder calcium pain best?
Symptom relief TerminatedThis study compares three non-surgical treatments—exercise therapy, shockwave therapy, and ultrasound-guided irrigation—against a wait-and-see approach for people with painful calcium deposits in the shoulder. About 116 participants with confirmed calcific tendinopathy will be ra…
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Which therapy loosens tight necks best? new study aims to find out
Symptom relief OngoingThis study compares two manual therapy techniques—Positional Release Technique and Post Isometric Relaxation—to see which better reduces pain, improves neck movement, and eases daily disability in people with tight levator scapulae muscles. About 44 adults aged 25 to 40 with neck…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Remote rehab: video calls may match In-Person therapy for Athletes' shoulder injuries
Symptom relief OngoingThis study compares physical therapy delivered through video calls to traditional in-person therapy for 50 young elite baseball players with rotator cuff problems. The goal is to see if remote therapy is as effective at improving shoulder function and reducing pain, and whether i…
Phase: NA • Sponsor: Taichung Veterans General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New shoulder surgery offers hope for massive rotator cuff tears
Symptom relief OngoingThis study tests a modified surgical technique for people with massive, irreparable rotator cuff tears. The procedure moves the lower trapezius tendon to help restore shoulder function. Twenty-five patients will be followed to see if pain decreases and shoulder ability improves.
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Progress reports may speed shoulder recovery
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether giving people with rotator cuff shoulder pain regular updates on their progress (like pain scores and strength) helps them recover better. 56 adults aged 18–35 will either get standard rehab or standard rehab plus these progress updates. The goal is to se…
Phase: NA • Sponsor: Elif Turgut • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a home breathing program help kids with duchenne?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a 6-week, caregiver-assisted breathing program done at home with remote coaching is practical and helpful for children with Duchenne muscular dystrophy. Twelve children will do breathing exercises, airway clearance, and relaxation techniques at least 5 ti…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New study tests biofeedback for better bathroom relief
Symptom relief ENROLLING_BY_INVITATIONThis study compares biofeedback training to lifestyle changes (like special positions and massage) for women with dyssynergic defecation, a condition where pelvic floor muscles don't relax properly during bowel movements. About 58 women aged 35-65 with chronic constipation will p…
Phase: NA • Sponsor: Ahram Canadian University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can a simple tape boost shoulder surgery recovery?
Symptom relief OngoingThis study looks at whether adding kinesio taping to standard rehab after rotator cuff surgery helps reduce pain and improve shoulder function. Fifty adults aged 18 to 70 who had surgery for a torn rotator cuff are randomly assigned to get either standard rehab alone or standard …
Phase: NA • Sponsor: Olcay Yavuz • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Simple exercises might soothe sore shoulders
Symptom relief OngoingThis study tests whether a specific type of exercise called eccentric contraction (lengthening muscles under tension) can help people with shoulder pain syndrome. Sixty adults aged 18-70 with rotator cuff tendinitis will do either eccentric exercises plus standard therapy or stan…
Phase: NA • Sponsor: Rafeef Hassan Asiri • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Could colored light be the new cure for Athlete's knee pain?
Symptom relief OngoingThis study tests whether adding yellow or green light therapy to standard care (ice and exercises) can reduce pain and improve knee function in 60 athletes with jumper's knee. Participants will receive either yellow light, green light, or standard care alone. The goal is to see i…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Tape trick: quick fix for aching shoulders?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether kinesio taping can quickly reduce pain, improve how far you can move your shoulder, and lessen fear of movement in people with rotator cuff syndrome. About 52 adults aged 18 to 65 with shoulder pain for at least 3 months will take part. Researchers wil…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can a special massage beat shoulder pain? new study investigates
Symptom relief OngoingThis study looks at whether adding deep friction massage to a standard exercise program helps people with bicipital tendinitis (a painful shoulder condition). Researchers will measure pain, movement ability, fear of movement, and quality of life in 42 adults aged 20-55. The goal …
Phase: NA • Sponsor: Firat University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Heat therapy offers hope for stubborn shoulder pain
Symptom relief OngoingThis small study tests a procedure called radiofrequency ablation for people with chronic shoulder pain that hasn't improved with standard treatments like physical therapy or injections. The treatment uses heat to calm the nerves that send pain signals from the shoulder joint. Te…
Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Which therapy wins for shoulder pain? new study tests two techniques
Symptom relief OngoingThis study looks at two different hands-on therapy methods (Mulligan and PNF) added to standard physical therapy for people with partial rotator cuff tears. 45 adults aged 30-70 will be split into three groups to see which approach best reduces pain, improves shoulder movement, a…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can balance exercises heal a torn rotator cuff?
Symptom relief OngoingThis study tests whether adding perturbation-based exercises (unexpected movements that challenge balance) to standard physiotherapy can improve pain, strength, and shoulder function in people with partial rotator cuff tears. Sixty adults aged 18–65 will be randomly assigned to e…
Phase: NA • Sponsor: Cumhuriyet University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Shock therapy for knees? device aims to rebuild muscle after ACL repair
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a neuromuscular electrical stimulation (NMES) device, used alongside standard physical therapy, can help people regain muscle strength more quickly after ACL reconstruction surgery. Twenty-five participants aged 15 to 50 will use the Zynex NexWave device …
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Ultrasound mirror for shoulder pain: new study tests Real-Time muscle training
Symptom relief ENROLLING_BY_INVITATIONThis study compares two ways to help people with shoulder pain activate important muscles: using real-time ultrasound images versus standard verbal or visual feedback. About 26 adults with shoulder pain will do exercises in a lab, and researchers will measure muscle activity and …
Phase: NA • Sponsor: California State University, Long Beach • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Could CBD and CBN ease your jaw pain and headaches?
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether a drink containing CBD and CBN can reduce facial pain and headaches caused by muscle tension. 42 adults with pain lasting over 3 months will be randomly assigned to receive either the CBD/CBN drink or a placebo. Researchers will measure pain and musc…
Phase: PHASE2, PHASE3 • Sponsor: Wroclaw Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New combo treatment aims to quiet jaw pain for TMD sufferers
Symptom relief OngoingThis study tests whether wearing a custom mouth splint and getting a granisetron injection into the jaw muscle reduces pain from temporomandibular disorders (TMD) better than the splint alone or with lidocaine. About 48 adults with jaw muscle pain will be followed for 6 months. T…
Phase: PHASE4 • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Pain relief showdown: injection vs. patch for back and neck pain
Symptom relief TerminatedThis study aimed to see if a lidocaine injection or a lidocaine patch works better for muscle pain in the neck and back. It was designed for adults visiting the emergency department. However, the study was withdrawn before any participants were enrolled.
Phase: PHASE4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Skip the sling? new study tests faster rehab after shoulder surgery
Symptom relief OngoingThis study compares two recovery programs after rotator cuff repair surgery. One group follows standard care—wearing a sling for 6 weeks with limited movement. The other group starts moving sooner, guided by comfort rather than strict restrictions. Researchers will measure should…
Phase: NA • Sponsor: Manchester University NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Walking while counting: new training may boost brain and body in DMD boys
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a dual-task training program—combining physical exercises like walking with mental tasks like counting—can improve both motor and cognitive function in 16 boys aged 6–12 with Duchenne muscular dystrophy. Participants will be randomly assigned to either st…
Phase: NA • Sponsor: Lokman Hekim University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief ENROLLING_BY_INVITATIONThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Hope for myotonic dystrophy: new drug shows promise in easing muscle stiffness Long-Term
Symptom relief ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of a drug called mexiletine PR for people with myotonic dystrophy types 1 and 2. The drug is taken once daily as a liquid to help reduce muscle stiffness (myotonia). The study includes 176 adults and teens who have alre…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Gentle rehab boost: blood flow cuffs may speed hip fracture recovery in seniors
Symptom relief OngoingThis pilot study tests whether adding blood flow restriction therapy to standard physical therapy helps elderly patients (65 and older) recover muscle strength and size after hip fracture surgery. Twenty participants will have their thigh and leg measurements, muscle strength, pa…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Neck pain breakthrough? collagen shots tested in new study
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether injecting collagen into the neck can reduce pain and inflammation in people with long-term neck muscle pain. Forty adults with chronic neck pain will receive either collagen or a standard painkiller injection over five weekly sessions. Researchers will me…
Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New device could replace opioids for weeks of pain relief after surgery
Symptom relief ENROLLING_BY_INVITATIONThis study tests a device called RELAY that delivers both local anesthetic and mild electrical pulses to nerves after shoulder or foot surgery. The goal is to provide up to 28 days of pain relief, much longer than current options. About 50 adults undergoing specific surgeries wil…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Study seeks optimal needling number for myofascial pain relief
Symptom relief ENROLLING_BY_INVITATIONThis study looks at how many times a needle should be passed through a trigger point to best relieve myofascial pain. 300 adults with chronic muscle pain will be randomly assigned to receive 2, 10, or 20 needle passes during their injection. Researchers will measure pain relief, …
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Should you sling it or skip it after shoulder surgery?
Symptom relief OngoingThis study looks at whether wearing a sling for three weeks after reverse shoulder replacement is better than wearing it for only three days. About 100 people having shoulder surgery at Duke University will be randomly assigned to one of the two groups. Researchers will track com…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Precision needle aims to ease jaw pain in new trial
Symptom relief OngoingThis study tests a computer-guided needle technique combined with a platelet-rich plasma (PRP) injection for people with a painful jaw joint condition called temporomandibular disorder (TMD). The goal is to see if the computer-guided method improves jaw function and reduces pain …
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New biologic injection takes on steroids for rotator cuff pain — but study pulled
Symptom relief TerminatedThis pilot study aimed to compare a single injection of connective tissue matrix (CTM) against a standard corticosteroid shot for treating rotator cuff tendinopathy. Participants would have been randomly assigned to one of the two injections and followed for six months with quest…
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Simple combo of exercise, fruit, and vitamins tested to reverse frailty in seniors
Symptom relief OngoingThis study tests whether a combination of exercise, fruit, and vitamin supplements can reduce frailty in older adults aged 65 to 80. About 934 participants with low physical activity and low fruit intake will be split into two groups: one receives the combined intervention three …
Phase: NA • Sponsor: Nanjing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Shoulder surgery without the OR? new study tests In-Office biceps tenotomy
Symptom relief OngoingThis study tests if a biceps tendon cutting procedure (tenotomy) done in the doctor's office with a tiny camera and local anesthesia works as well as the same surgery in an operating room. 14 adults with shoulder pain from biceps or rotator cuff problems will be enrolled. The mai…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could a common asthma drug help newborns breathe easier?
Symptom relief OngoingThis phase 3 trial tests whether inhaled salbutamol, a drug used for asthma, can help newborns with transient tachypnoea (rapid breathing after birth). About 608 babies born between 32 and 42 weeks will receive either salbutamol or a placebo. The goal is to see if the drug reduce…
Phase: PHASE3 • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Mind over muscle: imagining movements may boost shoulder surgery recovery
Symptom relief TerminatedThis study explores whether adding motor imagery (mentally practicing shoulder movements) to standard physical therapy improves muscle activity, pain, and function after arthroscopic rotator cuff repair. About 36 adults who have had this surgery will be split into two groups: one…
Phase: NA • Sponsor: Alanya Alaaddin Keykubat University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New exercise approach aims to ease rotator cuff pain
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether strengthening the latissimus dorsi muscle can improve shoulder space, reduce pain, and boost function in people with rotator cuff tendinopathy. 47 adults aged 18-50 with ongoing shoulder pain will be split into three groups: rotator cuff exercises only…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 26, 2026 17:07 UTC
-
New injection could rival PRP for shoulder pain relief
Symptom relief OngoingThis study compares two types of injections for people with shoulder pain caused by rotator cuff tendinopathy. One injection, CTM Boost, is made from donated placental tissue, and the other, PRP, uses a patient's own blood. The goal is to see if CTM Boost works as well as PRP at …
Phase: PHASE4 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 26, 2026 14:33 UTC
-
Wearable sensors could revolutionize monitoring of rare muscle disease
Knowledge-focused OngoingThis study tests whether wearable sensors worn on the wrist and as a pendant can accurately track changes in arm and leg function in people with inclusion body myositis (IBM), a rare muscle disease that causes progressive weakness. Researchers aim to see if these sensors can prov…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can ultrasound predict knee pain after broken leg surgery?
Knowledge-focused OngoingThis study follows 50 adults who had surgery for a broken shinbone to see if changes in the kneecap tendon's stiffness relate to knee pain. Researchers use a special ultrasound before and up to 6 months after surgery. The goal is to better understand why some people develop front…
Sponsor: Bagcilar Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Shoulder surgery secrets: anchor angle may determine healing success
Knowledge-focused OngoingThis study looks at how the position and angle of surgical anchors used in rotator cuff repair affect cyst formation and tendon healing. Researchers will use MRI scans to measure cyst volume and assess tendon recovery in 70 adults aged 18–70 undergoing primary arthroscopic repair…
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Biggest ALS gene study aims to unlock disease secrets
Knowledge-focused OngoingThis study looks at people with ALS and similar diseases like frontotemporal dementia and hereditary spastic paraplegia. Researchers want to understand how genes affect the disease and find biological markers (biomarkers) to help develop future treatments. About 708 participants,…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to sharpen tools for tracking becker muscular dystrophy
Knowledge-focused OngoingThis 24-month observational study will follow 80 people with Becker muscular dystrophy (BMD) to better understand how the disease progresses. Researchers will measure muscle strength, walking speed, breathing, and heart function using standard tests. The goal is to identify which…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Paving the way: new study aims to sharpen tools for LGMD R1 trials
Knowledge-focused OngoingThis 24-month observational study follows 100 people aged 12–50 with Limb Girdle Muscular Dystrophy type R1 (LGMD R1). Researchers will test whether a motor function scale called NSAD and muscle fat measurements from MRI can reliably track disease progression. The goal is to vali…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New MRI coils aim to sharpen images for children
Knowledge-focused OngoingThis study tests new radio frequency coils for MRI scanners to see if they can produce better images in children, including those with Duchenne muscular dystrophy. Researchers will check for side effects like heating and discomfort, and measure image quality. The goal is to impro…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingThis study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such a…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Weekly Check-Ins could boost patient satisfaction for chronic pain
Knowledge-focused TerminatedThis study looked at whether having more frequent contact with a clinician (at least once a week) improves satisfaction for people with long-lasting musculoskeletal conditions. Participants were split into two groups: one with standard contact and one with extra check-ins via tex…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Shoulder injury may throw off your whole Body's balance, study finds
Knowledge-focused OngoingThis study looks at how rotator cuff injuries—common causes of shoulder pain—might affect posture, trunk rotation, and balance. Researchers will compare 40 people with rotator cuff problems to 40 healthy volunteers, measuring things like spine curvature and balance using smartpho…
Sponsor: Yuzuncu Yil University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Muscle recovery differs between sexes, new study reveals
Knowledge-focused OngoingThis study looks at how middle-aged men and women lose muscle after a week of not using one leg, and how they recover with exercise. Researchers will measure muscle strength, size, and genetic activity to find sex-specific differences. The goal is to learn more so future treatmen…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New study tracks how DM1 affects chinese patients over time
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1000 Chinese patients with myotonic dystrophy type 1 (DM1) to understand how the disease affects multiple body systems and leads to disability. Researchers will collect health data and blood samples every 3 to 6 months for several years. The goal is to identify…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to perfect how we measure muscle recovery in ICU survivors
Knowledge-focused OngoingThis study looks at whether a tool called the Chelsea Critical Care Physical Assessment tool (CPAx) can accurately track recovery in 120 adults who developed muscle weakness after being on a breathing machine in the ICU. The goal is to find the smallest meaningful improvement tha…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New study tracks rare muscle disease without offering treatment
Knowledge-focused OngoingThis study follows 150 adults with sporadic inclusion body myositis (sIBM) for two years to see how the disease progresses. Participants visit the clinic every six months for tests like muscle strength, breathing, and swallowing. No treatments are given—the goal is to learn more …
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain scans reveal diabetes link to cognitive decline in rare disease
Knowledge-focused OngoingThis study looks at whether diabetes or blood sugar problems can worsen thinking and memory issues in people with myotonic dystrophy type 1. Researchers will use MRI brain scans and thinking tests over 4 years to track changes. The goal is to understand why some patients have mor…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a special clinic get workers back on the job faster? norway launches massive study.
Knowledge-focused OngoingThis study tests whether a Norwegian clinic (NSAC) helps people with common mental health issues or muscle pain return to work sooner. 2500 adults are split into three groups: one gets treatment quickly, one waits 10-14 weeks, and one gets a basic check-up. Researchers will track…
Phase: NA • Sponsor: Nordlandssykehuset HF • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny tags track tendon healing after shoulder surgery
Knowledge-focused OngoingThis study looks at how the repaired rotator cuff tendon moves after surgery, which may affect recovery. 125 people getting rotator cuff repair will have small markers placed on the tendon during surgery. CT scans and MRIs over 5 years will track tendon position and healing, and …
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a VR game make rehab fun for kids with duchenne?
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a virtual reality game designed specifically for people with Duchenne muscular dystrophy (DMD). Six participants aged 7 and older will play the game once using a VR headset and hand tracking. Researchers will measure how easy and enjoyable the game is, and w…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could your genes predict rotator cuff tears?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether rotator cuff disease runs in families. Researchers will collect DNA, medical history, and family history from 400 people to understand genetic risk factors. The goal is to build a resource for future studies, not to test a new treatment.
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to uncover hidden cancer clues in autoimmune disease
Knowledge-focused OngoingThis study examines blood samples from 50 people with dermatomyositis, an autoimmune disease that raises the risk of cancer. Researchers are looking for new antibodies and immune molecules that might signal which patients are more likely to develop cancer. The goal is to improve …
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Antioxidant cocktail may shield seniors from bed rest damage
Knowledge-focused OngoingThis study looks at whether antioxidant supplements can prevent muscle loss and blood vessel problems in older adults (ages 65-85) during five days of bed rest. Participants take either a placebo or two antioxidants (MITO-AO and PB-125) while researchers measure changes in blood …
Phase: NA • Sponsor: Joel Trinity • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New model aims to speed up rare disease diagnosis
Knowledge-focused OngoingThis study is testing a new way to care for people with rare diseases. It will use advanced genetic testing and a team of specialists to help diagnose patients faster and coordinate their care better. The study involves 136 participants with certain rare diseases and aims to redu…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New pilot study tests In-Utero treatment for rare birth defect
Knowledge-focused TerminatedThis pilot study aims to learn more about a procedure called FETO for unborn babies with a severe form of congenital diaphragmatic hernia (CDH). The researchers want to see if placing a balloon in the baby's windpipe before birth can help the lungs grow and improve survival. The …
Phase: NA • Sponsor: Eyal Krispin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Shoulder surgery study pulled before it started: one anchor or two?
Knowledge-focused TerminatedThis study was designed to compare two standard surgical techniques for bicep tenodesis—using one anchor or two mini anchors—to see which keeps the tendon in place better. It planned to track tendon movement with X-rays right after surgery, at 2 weeks, and at 6 months. However, t…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Bone marrow secrets could boost shoulder surgery success
Knowledge-focused OngoingThis study explores whether the characteristics of bone marrow in the upper arm bone can predict how well a torn rotator cuff heals after surgery. Researchers will enroll 50 adults aged 18-75 with full-thickness tears and use MRI and CT scans to measure tendon healing. The goal i…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
AI and PET scans join forces to spot lung trouble in rare muscle disease
Knowledge-focused OngoingThis study looks at 200 people with dermatomyositis, a rare muscle disease that often affects the lungs. Researchers are using special PET/CT scans and machine learning to create a model that can better predict if a patient has interstitial lung disease. The goal is to improve di…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gift cards or education: which gets patients to fill out surveys?
Knowledge-focused OngoingThis study looks at ways to get patients to complete follow-up surveys after shoulder surgery. About 400 adults having shoulder arthroscopy will either receive education about the importance of surveys or get Amazon gift cards for completing them. The goal is to see which method …
Phase: NA • Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
UK study tracks rare muscle disease to pave way for future treatments
Knowledge-focused OngoingThis study follows 45 people with nemaline myopathy in the UK to learn how the disease naturally progresses. Researchers collect medical exams, quality-of-life surveys, and physical assessments over time. The goal is to identify the best ways to measure the disease in future clin…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New tools aim to speed up FSHD drug trials
Knowledge-focused OngoingThis study involves 324 adults with facioscapulohumeral muscular dystrophy (FSHD) across 14 international sites. Researchers are testing two new measurement tools—a functional test called FSHD-COM and a muscle-impedance device—to better track disease progression. The goal is to i…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can exosomes heal jaw pain? new lab study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at tiny particles called exosomes, taken from a patient's own platelet-rich plasma, to see if they might help repair jaw joints. Researchers will compare these exosomes with other blood products in lab tests on cells. The goal is to understand their content and p…
Sponsor: Wroclaw Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Rotator cuff study pulled before it even started
Knowledge-focused TerminatedThis study was designed to follow patients with full-thickness rotator cuff tears over 10 years to see how their shoulder function and quality of life changed. It aimed to identify factors linked to improvement. However, the study was withdrawn before enrolling any participants, …
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused TerminatedThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to uncover why people with muscle disease fall
Knowledge-focused OngoingThis study measures how often people with myotonic dystrophy type 1 fall and what factors affect their balance. Researchers will also assess fear of falling and leg muscle strength. The goal is to better understand fall risk in this condition.
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Grinding your teeth? it might be connected to pelvic pain and erectile dysfunction
Knowledge-focused ENROLLING_BY_INVITATIONThis study is investigating whether bruxism (teeth grinding or clenching) is associated with pelvic pain, erectile dysfunction, and anxiety in young men aged 18-30. Researchers will use questionnaires and physical exams to assess 100 participants. The goal is to better understand…
Sponsor: Akdeniz University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New scanner aims to see pain in the Body's tissues
Knowledge-focused OngoingThis study uses a special total-body PET/CT scanner to take detailed images of muscles and tissues in people with chronic low back pain caused by myofascial pain. The goal is to find new ways to measure pain-related changes in the body, such as blood flow and tissue health. Fifty…
Phase: EARLY_PHASE1 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Could your jaw pain be connected to pelvic floor issues? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores whether bruxism (teeth grinding or clenching) is related to pelvic floor dysfunction in young women aged 18-30. Researchers will use questionnaires and physical exams to assess jaw function, pelvic floor symptoms, and anxiety in 100 participants. The goal is t…
Sponsor: Akdeniz University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Massive PT study mines 4 million records to find what works best
Knowledge-focused OngoingThis study looks back at the medical records of about 4 million people who had physical or occupational therapy for muscle and joint problems. Researchers want to see if different ways of giving therapy lead to different results. No new treatments are tested—the goal is to learn …
Sponsor: ATI Holdings, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Could your blood predict jaw pain? new study investigates cannabinoid receptors
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores whether the levels of certain receptors (CB1, CB2, TRPV-1) in the blood are linked to chronic orofacial pain from jaw muscles. Researchers will compare 102 adults with and without this pain, using blood tests and clinical exams. The goal is to understand how t…
Sponsor: Wroclaw Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Phone app vs. doctor: can a mobile tool catch infections after surgery?
Knowledge-focused TerminatedThis study aimed to see if a mobile monitoring tool could accurately identify surgical site infections (SSIs) in orthopedic surgery patients, compared to the usual manual review. The study was withdrawn before enrolling any participants, so no results are available. It was design…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study probes arm muscle stiffness in duchenne patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how the muscles in the arms and hands change in people with Duchenne muscular dystrophy (DMD). Researchers will measure muscle tone, stiffness, and elasticity using a device called MyotonPRO. They will also test hand function and muscle strength. The goal is t…
Sponsor: Sanko University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Brain-Body link: new study explores thinking skills in kids with DMD
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how thinking skills (called executive functions) relate to everyday activities like self-care and play in children with Duchenne muscular dystrophy (DMD). Researchers will compare 38 children with DMD to healthy children using surveys and functional tests. The…
Sponsor: Lokman Hekim University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Researchers track Long-Term effects of duchenne gene therapy
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 400 people with Duchenne muscular dystrophy who have already received the gene therapy SRP-9001 in an earlier study. The goal is to monitor their safety and muscle function over time. No new treatment is given in this study.
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
ICU muscle mystery: new study aims to uncover why patients stay weak
Knowledge-focused OngoingThis study looks at why over half of ICU patients develop severe muscle weakness that can last for months or years. Researchers will use muscle biopsies, ultrasound, and strength tests on 50 critically ill adults to find better ways to diagnose and track this condition. The goal …
Phase: NA • Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks muscle decline in rare muscular dystrophy
Knowledge-focused OngoingThis study follows 25 people with limb-girdle muscular dystrophy type 2A (LGMD2A), a rare genetic disease that causes progressive muscle weakness. Researchers will measure how muscle strength changes over time and how it affects quality of life. The goal is to better understand t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Scientists build heart cells in a dish to unravel genetic heart disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood or skin samples from 100 adults with inherited heart rhythm disorders (like Long QT Syndrome or Brugada Syndrome) and healthy volunteers. Researchers will turn these samples into stem cells and then into heart cells to study how these diseases work and t…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Massive gene hunt launched for mysterious mitochondrial diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to discover new genetic mutations that cause mitochondrial disorders by analyzing tissue samples from up to 6,900 participants. It includes people with suspected or known mitochondrial diseases, such as MELAS or Leigh's Disease, who lack a genetic diagnosis. The r…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
ICU survivors: new study probes hidden kidney and muscle damage
Knowledge-focused TerminatedThis study looks at 100 people who spent at least a week in the ICU and had kidney injury. Researchers will measure kidney function, muscle loss, and bone health to understand long-term effects. The goal is to improve follow-up care for ICU survivors.
Sponsor: University of Liege • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Researchers probe hidden jaw pain in nerve disorder patients
Knowledge-focused TerminatedThis study aimed to find out how many people with trigeminal neuralgia (a severe facial nerve pain condition) also have temporomandibular disorder (TMD), which causes jaw pain. Researchers planned to follow patients from three clinics and test a questionnaire to better diagnose b…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Hidden muscle wasting in ICU: new study to reveal true toll
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how often muscle loss (sarcopenia) happens in adults who need a breathing machine in the ICU for more than 48 hours. Researchers will measure muscle health using simple tests and ultrasound. The goal is to understand how common this problem is and how it chang…
Sponsor: Hospital Mutua de Terrassa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New study aims to speed up FSHD drug development
Knowledge-focused OngoingThis study is working to create better tools for measuring muscle function in people with facioscapulohumeral muscular dystrophy (FSHD). Researchers will follow 100 adults with FSHD for up to 24 months, testing new ways to track disease progression. The goal is to make future cli…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Heart scans aim to uncover hidden damage in duchenne patients
Knowledge-focused TerminatedThis study was designed to track heart muscle changes in people with Duchenne muscular dystrophy using two cardiac MRIs taken two years apart, along with blood tests for heart failure markers. It planned to enroll participants aged 6 and older with a confirmed genetic diagnosis. …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
3D imaging could offer new way to diagnose diaphragm dysfunction
Knowledge-focused OngoingThis study tests a new 3D imaging method to measure how much air the lungs can hold in people with suspected diaphragm weakness. About 100 adults will have two quick 3D scans while holding their breath. The goal is to see if this technique gives reliable results compared to stand…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Scientists watch LGMD progress in 205 patients over years
Knowledge-focused OngoingThis study follows 205 people with four types of limb-girdle muscular dystrophy (LGMD) to understand how the disease changes over time. Participants will have their muscle strength, movement, and breathing tested regularly for up to 5 years. No treatment is given; the goal is to …
Sponsor: Sarepta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Researchers track shoulder implant longevity to improve future surgeries
Knowledge-focused OngoingThis study gathers information from 160 people who received a shoulder implant to see how long the implant lasts and how safe it is. Participants have conditions like arthritis or fractures. The goal is to use this data to make better implants and help doctors and patients make i…
Sponsor: Zimmer Biomet • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New MRI method could unlock secrets of chronic muscle pain
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a new imaging method called MR Elastography to measure how muscles and their surrounding tissues move in people with myofascial pain syndrome. Researchers will compare results from 106 participants, including those with chronic pain and healthy volunteers. The go…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New implant for torn shoulder tendons gets closer look with MRI
Knowledge-focused OngoingThis study looks at how well a bio-inductive implant helps heal torn rotator cuff tendons in the shoulder. Researchers will use MRI scans at 3 and 6 months after surgery to check if the repair is holding and if there are any problems. About 20 people with partial or full tears wi…
Sponsor: Foundation for Orthopaedic Research and Education • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to map rare muscle disease progression
Knowledge-focused TerminatedThis study was designed to track the natural course of gamma-sarcoglycanopathy (LGMDR5), a rare muscle-weakening disease, over two years. Researchers planned to measure changes in muscle strength, walking ability, and daily function in patients aged 6 to 35. The goal was to bette…
Sponsor: Atamyo Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
CF Drug's hidden impact on bones and muscles revealed
Knowledge-focused OngoingThis study looks at how CFTR modulators, a type of cystic fibrosis treatment, affect bone strength and muscle mass in adults with CF. Researchers will measure changes in bone density and lean body mass over 12 to 24 months. The goal is to understand whether these treatments help …
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Immune cell showdown: autoimmune vs. infection vs. healthy
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at immune cells from people with autoimmune diseases (like lupus), people with infections, and healthy volunteers. Researchers want to understand how these cells differ and what makes them attack the body in autoimmune conditions. The study involves blood and bon…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Tiny power plants in cells may weaken bones, new study hints
Knowledge-focused OngoingThis study looks at how problems with mitochondria—the tiny power plants inside cells—might affect bone health. Researchers will compare 30 people with certain genetic changes that cause mitochondrial dysfunction to healthy volunteers. They will take blood, bone marrow, and bone …
Phase: NA • Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
MS study probes hidden link between stiff muscles, breathing, and mood
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how the stiffness of leg and breathing muscles relates to lung function, fatigue, and anxiety or depression in people with multiple sclerosis (MS). About 29 adults with MS will have their muscle properties measured with a device, take breathing tests, and fill…
Sponsor: Sanko University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New study aims to spot hidden breathing muscle damage from heart procedure
Knowledge-focused TerminatedThis study looks at a possible side effect of a heart treatment called PFA for atrial fibrillation: injury to the phrenic nerve, which can paralyze part of the diaphragm and affect breathing. Patients get a special X-ray before and after the procedure to check diaphragm movement.…
Sponsor: Laurent Macle • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New shoulder implant under watch: how well does it last?
Knowledge-focused OngoingThis study follows 200 adults who received the Medacta Shoulder System to treat various shoulder issues like arthritis, fractures, or rotator cuff problems. The main goal is to see how long the implant lasts and how well the shoulder works after surgery. It is a post-market check…
Sponsor: Medacta International SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New tools to track FSHD in wheelchair users
Knowledge-focused OngoingThis study aims to find better ways to measure disease progression in people with advanced facioscapulohumeral muscular dystrophy (FSHD) who use wheelchairs. Researchers will test various muscle strength and function tests over two years in 30 adults. The goal is to develop relia…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Real-World data sought on DMD Exon-Skipping drugs
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study will follow 300 people with Duchenne muscular dystrophy who are already taking exon-skipping therapies (eteplirsen, golodirsen, or casimersen) as part of their routine care. Researchers will collect data on movement, lung function, and heart function over…
Sponsor: Sarepta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:35 UTC
-
New study aims to design better braces for FSHD patients using MRI and motion capture
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study will enroll 40 adults with facioscapulohumeral muscular dystrophy (FSHD) to understand how muscle degeneration affects movement. Researchers will use MRI to assess muscle health and 3D motion capture to analyze walking and posture. The goal is to create a…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:29 UTC
-
Waterproof cast study for kids pulled before it began
Knowledge-focused TerminatedThis study planned to compare waterproof and standard casts in children with ankle or foot injuries. The goal was to see if waterproof casts lead to more complications. However, the study was withdrawn before enrolling any participants, so no data or conclusions are available.
Phase: NA • Sponsor: West Virginia University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:36 UTC